남성호르몬차단요법을 받는 전립선암 환자의 치료기간에 따른 신체증상, 우울, 부부친밀도, 삶의 질 비교
Comparison of Symptoms, Depression, Intimacy, and Quality of Life According to Treatment Duration in Men with Prostate Cancer Undergoing Androgen Deprivation Therapy
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: This study was conducted to identify the differences in symptoms, depression, intimacy and quality of life (QOL), and the factors influencing QOL in men with prostate cancer undergoing androgen deprivation therapy (ADT). Methods: This study used a cross-sectional, descriptive research design. Data were collected using a self-report questionnaire from 122 men with prostate cancer undergoing ADT. The data collection period was from November 19, 2018 to February 25, 2019. Data were analyzed using t-tests, χ2 tests, Fisher’s exact tests, 4-way ANOVA and multiple regression. Results: The mean age of the men was 70.3±7.3. There were statistically significant differences in urinary, bowel, sexual and hormonal symptoms according to treatment duration (F=23.74, p<.001). Factors influencing QOL explained 55% of the variance (adjusted R2=.55, p<.001). These factors were depression (β=-.52, p<.001), intimacy (β=.23, p=.001), ADT duration (β=-.17, p=.011), economic status middle (β=.23, p=.006), high (β=.29, p=.001) and sleep (β=.15, p=.023). Conclusion: The study found an association between ADT duration and symptoms, and the factors influencing QOL of participants. It provides a base for future research direction on ADT and patient QOL.
Abstract
Purpose: This study was conducted to identify the differences in symptoms, depression, intimacy and quality of life (QOL), and the factors influencing QOL in men with prostate cancer undergoing androgen deprivation therapy (ADT). Methods: This study used a cross-sectional, descriptive research design. Data were collected using a self-report questionnaire from 122 men with prostate cancer undergoing ADT. The data collection period was from November 19, 2018 to February 25, 2019. Data were analyzed using t-tests, χ2 tests, Fisher’s exact tests, 4-way ANOVA and multiple regression. Results: The mean age of the men was 70.3±7.3. There were statistically significant differences in urinary, bowel, sexual and hormonal symptoms according to treatment duration (F=23.74, p<.001). Factors influencing QOL explained 55% of the variance (adjusted R2=.55, p<.001). These factors were depression (β=-.52, p<.001), intimacy (β=.23, p=.001), ADT duration (β=-.17, p=.011), economic status middle (β=.23, p=.006), high (β=.29, p=.001) and sleep (β=.15, p=.023). Conclusion: The study found an association between ADT duration and symptoms, and the factors influencing QOL of participants. It provides a base for future research direction on ADT and patient QOL.
참고문헌 (30)
- "National Cancer Information Center"[URL]
- Grunfeld EA, "Andropause syndrome in men treated for metastatic prostate cancer: a qualitative study of the impact of symptoms", Cancer Nurs, 35, pp.63~69 (2012)
- Benedict C, "Sexual bother in men with advanced prostate cancer undergoing androgen deprivation therapy", J Sex Med, 11, pp.2571~2580 (2014)
- Lee M, "Depressive symptomatology in men receiving androgen deprivation therapy for prostate cancer : a controlled comparison", Psychooncology, 24, pp.472~477 (2015)
- Sevilla C, "Long-term quality of life in disadvantaged men with prostate cancer on androgen-deprivation therapy", Prostate Cancer Prostatic Dis, 15, pp.237~243 (2012)
- Baker H, "Functional quality-of-life outcomes reported by men treated for localized prostate cancer : a systematic literature review", Oncol Nurs Forum, 43, pp.199~218 (2016)
- Donovan KA, "Effect of androgen deprivation therapy on sexual function and bother in men with prostate cancer : a controlled comparison", Psychooncology, 27, pp.316~324 (2018)
- Baguley BJ, "Nutrition therapy with high intensity interval training to improve prostate cancer-related fatigue in men on androgen deprivation therapy : a study protocol", BMC Cancer, 17, pp.1~ (2017)
- Ahmadi H, "Androgen deprivation therapy : evidencebased management of side effects", BJU Int, 111, pp.543~548 (2013)
- 양금자, "근치적 전립선절제술이나 호르몬치료 후의 건강관련 삶의 질과 우울", Asian Oncology Nursing, 13(4), pp.248~255 (2013), 대한종양간호학회
- Watts S, "Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates", BMJ Open, 4, pp.e003901~ (2014)
- 조현민, "부인암 환자의 우울, 가족지지가 회복탄력성에 미치는 영향", 한국웰니스학회지, 10(4), pp.183~195 (2015), 한국웰니스학회
- Colloca G, "The effects of social support on health-related quality of life of patients with metastatic prostate cancer", J Cancer Educ, 31, pp.244~252 (2016)
- Kim SC, "Characteristics of prostate cancer that underwent prostatectomy at young age", pp.2010
- Wei JT, "Development and validation of the expanded prostate cancer index composite(EPIC)for comprehensive assessment of health-related quality of life in men with prostate cancer", Urology, 56, pp.899~905 (2000)
- 정경진, "Development and Validation of the Korean Version of Expanded Prostate Cancer Index Composite: Questionnaire Assessing Health-Related Quality of Life after Prostate Cancer Treatment", Investigative and Clinical Urology, 51(9), pp.601~612 (2010), 대한비뇨의학회
- Radloff LS, "The CES-D scale : a self-report depression scale for research in the general population", Appl Psychol Meas, 1, pp.385~401 (1977)
- Chon KK, "Integrated adaptation of CES-D in Korea", Korean J Health Psychol, 6, pp.59~76 (2001)
- Lee KH, "A measure of marital intimacy", J Korean Home Econ Assoc, 33, pp.235~249 (1995)
- Alibhai SM, "Long-term impact of androgen-deprivation therapy on physical function and quality of life", Cancer, 121, pp.2350~2357 (2015)
- Punnen S, "Longterm health-related quality of life after primary treatment for localized prostate cancer : results from the CaPSURE registry", Eur Urol, 68, pp.600~608 (2015)
- Lee SJ, "The degree of elderly sexual desire and their attitudes towards sex", Korean J Clin Soc Work, 10, pp.1~21 (2013)
- Tripp DA, "Biopsychosocial impact of prostate cancer and androgen-deprivation therapy", Can Urol Assoc J, 11, pp.338~343 (2017)
- 오순영, "전립선암환자의 성건강 교육요구와 우울, 삶의 질", Asian Oncology Nursing, 15(3), pp.163~170 (2015), 대한종양간호학회
- Nead KT, "Association of androgen deprivation therapy and depression in the treatment of prostate cancer : a systematic review and meta-analysis", Urol Oncol, 35, pp.664.e1~664.e9 (2017)
- Beck AM, "Sexual values as the key to maintaining satisfying sex after prostate cancer treatment : the physical pleasure-relational intimacy model of sexual motivation", Arch Sex Behav, 42, pp.1637~1647 (2013)
- 이인정, "암환자와 배우자의 부부적응에 대한 부부의사소통의 영향 - 자기효과와 상대방효과를 중심으로 -", 한국사회복지학, 63(2), pp.179~205 (2011), 한국사회복지학회[DOI]
- 남금희, "전립선암 수술 환자의 불확실성, 불확실성 평가가 삶의 질에 미치는 영향", Asian Oncology Nursing, 17(1), pp.45~54 (2017), 대한종양간호학회
- 전성숙, "전립선암환자의 수면장애", 기본간호학회지, 17(2), pp.169~176 (2010), 기본간호학회
- Gagliano-Jucá T, "Effects of androgen deprivation therapy on pain perception, quality of life, and depression in men with prostate cancer", J Pain Symptom Manage, 55, pp.307~317.e1 (2018)